NCT04183673

Brief Summary

Objective To investigate the effectiveness of the use of the QMD Helios Laser device in association with standard rehabilitation therapy in reducing inflammatory symptoms in patients following total knee replacement. Design Randomized controlled trial. Setting Rehabilitation structure, inpatient Main outcome measures Pain subscale of the WOMAC and Lequesne's Algo-Functional Index (LIKERT scale), knee circumference (measured at the middle line of the knee joint space) and knee flexion /extension range of motion by goniometer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 3, 2019

Completed
Last Updated

April 1, 2022

Status Verified

March 1, 2022

Enrollment Period

8 months

First QC Date

November 19, 2019

Last Update Submit

March 31, 2022

Conditions

Keywords

Laser TherapyCryotherapyThermotherapyRehabilitationknee replacement

Outcome Measures

Primary Outcomes (3)

  • Change in Womac Pain subscale

    Pain subscale of the Western Ontario and McMaster Universities Activity Index (scored on a five point (0-4) LIKERT scale)

    Before treatment (admission) and after treatment (3 weeks after admission)

  • Change in knee circumference

    Knee circumference measured at the middle line of the knee joint space

    Before treatment (admission) and after treatment (3 weeks after admission)

  • Change in Lequesne's algo Functional Index

    Lequesne's algo Functional Index (scored on a five point (0-4) LIKERT scale)

    Before treatment (admission) and after treatment (3 weeks after admission)

Study Arms (2)

Laser-cryo-usual care

EXPERIMENTAL

Sessions 5 days a week for 3 weeks. Each session includes laser therapy+ cryo-thermal followed by standard rehabilitation program

Procedure: Laser therapy-cryo thermal therapy

usual care

ACTIVE COMPARATOR

Sessions 5 days a week for 3 weeks. Each session includes only standard rehabilitation program

Procedure: Usual care

Interventions

5 days per week, 3 weeks, sessions including laser therapy + cryo therapy followed by usual rehabilitation

Laser-cryo-usual care
Usual carePROCEDURE

5 days per week, 3 weeks, sessions of usual rehabilitation

usual care

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • good general physical conditions
  • first total knee replacement

You may not qualify if:

  • diabetic neuropathy
  • renal or hearth disease
  • allergic reactions
  • Reynaud's disease
  • lupus
  • rheumatoids arthritis
  • peripheral vascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ICS Maugeri, Montescano Rehabilitation Center

Montescano, Pavia, 27040, Italy

Location

MeSH Terms

Conditions

Hyperthermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsHeat Stress DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2019

First Posted

December 3, 2019

Study Start

May 29, 2018

Primary Completion

January 31, 2019

Study Completion

February 28, 2019

Last Updated

April 1, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations